< 1 minute read
Sep. 18, 2021
ETX0282: An Oral Prodrug of Serine-Lactamase Inhibitor
ETX0282
oral prodrug of serine _-lactamase inh. in dev. for multidrug resistant bact. infection from optimization of prior _-lactamase inh. J. Med. Chem., Jul. 24, 2020 Entasis Therapeutics, Waltham, MA